Joseph San Filippo

This inventor holds 11 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 4 EPO patents. Top assignees: Roche Molecular Systems, Inc., Other. Active years: 2014-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph San Filippo. Retrieved from https://idiyas.com/inventor/joseph-san-filippo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 4

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 9(Granted Patents)

Company Filing History:

10 out of 646

Roche Molecular Systems, Inc.

patents

1 out of 834,570

Other

patents

Years Active: 2014-2020

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10724016 - DNA polymerases with increased 3'-mismatch discrimination (2020-07-28),

2. 10689718 - HEV Assay (2020-06-23),

3. 10683540 - Oligonucleotide inhibitor of DNA polymerases (2020-06-16),

4. 10597644 - DNA polymerases with improved activity (2020-03-24),

5. 10036061 - Oligonucleotide inhibitor of DNA polymerases (2018-07-31),

6. 9988613 - DNA polymerases with increased 3'-mismatch discrimination (2018-06-05),

7. 9702017 - HEV assay (2017-07-11),

8. 9637726 - Methods for conducting primer extension using DNA polymerases with improved activity (2017-05-02),

9. 9410174 - DNA polymerases with increased 3'-mismatch discrimination (2016-08-09),

10. 9017979 - DNA polymerases with improved activity (2015-04-28),

11. 8735120 - DNA polymerases with increased 3'-mismatch discrimination (2014-05-27),

Title: Innovations of Joseph San Filippo: Pioneering DNA Polymerase Technologies

Introduction

Joseph San Filippo, based in Dublin, California, is a prolific inventor with a remarkable portfolio of 11 patents. His contributions primarily lie in the field of biotechnology, focusing on advancements in DNA polymerase technologies and assays for the Hepatitis E virus (HEV). His innovative work continues to impact scientific research and diagnostics.

Latest Patents

Among his latest patents is a groundbreaking invention of mutant DNA polymerases that exhibit increased 3'-mismatch discrimination. This significant enhancement allows for more accurate primer extension methods, which are crucial in various genetic analyses. In another noteworthy patent, Joseph has developed a method for simultaneously amplifying genotypes 1, 2, 3, and 4 of HEV. This method utilizes a single none-degenerate forward primer overlapping the 5'UTR region of HEV and at least one reverse primer, thereby streamlining the detection process. Both patents also include related compositions and kits essential for the effective application of these technologies in laboratory settings.

Career Highlights

Throughout his career, Joseph has worked with reputable organizations, including Roche Molecular Systems, Inc., where he contributed to significant advancements in molecular diagnostics. His work has been instrumental in enhancing the capabilities of laboratories to perform complex genetic analyses.

Collaborations

Joseph San Filippo has collaborated with notable professionals in the industry, including Thomas W. Myers and Keith Bauer. These collaborations have facilitated the sharing of knowledge and expertise, leading to innovative solutions in the field of molecular biology and diagnostics.

Conclusion

Joseph San Filippo's contributions to the field of biotechnology, particularly through his patented inventions, underscore the importance of innovation in scientific research. His work with DNA polymerases and HEV assays not only demonstrates his expertise but also showcases his commitment to advancing medical diagnostics and genetic research. As he continues to innovate, Joseph remains a pivotal figure in shaping the future of biotechnology.

Profile summary based on public USPTO records.